Only patients with anemia (e.g., Hb <9–10 g/dl) and concomitant tissue hypoxia (e.g., PbtO2 <15–20 mmHg, SvjO2 <55 %) should be considered as potential candidates for RBCT. Here, GSTM1 is linked to anemia.